FDA recall record

Dkiru Adndale Magnesium Glycinate Gummies 400 mg recall — FDA H-1079-2026

Undeclared melatonin.

Class IIclassification
H-1079-2026official record ID
Jun 24, 2026report date

Recall record at a glance

Official recordH-1079-2026
CategoryFood Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmDkiru LLC
Report dateJun 24, 2026
Recall initiation dateMay 12, 2026
Quantity13,920 bottles
LocationSheridan, WY, United States

Official product description

Adndale Magnesium Glycinate Gummies 400 mg. Plastic bottle containing 90 gummies. Net weight: 11.36 ounces. Serving size: 2 gummies. UPC: 860008784551 Firm name and address listed on label: Dkiru Ltd, Keepers Cottage, 3 Dublin Rd, Leixlip, Co. Kildare W23 H3C4, Ireland

Why the product was recalled

Undeclared melatonin.

Distribution information

Will be provided when available.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.